Back to discover
Disease
Meningeal Carcinomatosis
Clinical development underwayEmerging research
1
Publications
1
Clinical trials
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
1
0
0
0
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes1
- Meningeal Neoplasms1
Leading journals1
- Neuro-oncology1
Leading researchers8
- Ahn MJ1
- Aizer AA1
- Bale TA1
- Boire AA1
- Brandsma D1
- Brastianos PK1
- Chang S1
- Chukwueke UN1
Affiliations (unnormalised)6
- Baylor College of Medicine1
- Brigham and Women's Hospital / Dana-Farber Cancer Institute1
- Castelfranco Veneto and Treviso Hospitals1
- Center for Neuro-Oncology1
- Clinical Neuroscience Center1
- H. Lee Moffitt Cancer Center and Research Institute1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.